Design and production of challenge Agents
CHIMunomics aims at intelligent design and cGMP-like production of human challenge agents. The founders of CHIMunomics have significant experience in making high quality challenge agents, successfully manufacturing an influenza A H3N2 (A/Belgium/4217/2015 (H3N2) and an RSV challenge inoculum (RSV-NICA) for commercial usage as well as decades of experience in the infectious disease prophylactics and therapeutics industry. CHIMunomics aims to coordinate the manufacture of benchmark challenge agents both for single use proof-of-concept and efficacy studies and for basic research, such as correlates of protection or contagion, without unnecessary commercial or academic restrictions. Such agents will be available for manufacture and/or sale to whoever is qualified and authorised to perform human challenge trials.
Every website has a story, and your visitors want to hear yours. This space is a great opportunity to give a full background on who you are, what your team does and what your site has to offer. Double click on the text box to start editing your content and make sure to add all the relevant details you want site visitors to know.
If you’re a business, talk about how you started and share your professional journey. Explain your core values, your commitment to customers and how you stand out from the crowd. Add a photo, gallery or video for even more engagement.